BACK TO NEWS
Longitudinal analysis of blood markers reveals progressive loss of resilience and predicts human lifespan limit
Partnership Release
Event
News
Publication
May 25, 2021

Nature Communications

We investigated the dynamic properties of the organism state fluctuations along individual aging trajectories in a large longitudinal database of CBC measurements from a consumer diagnostics laboratory. To simplify the analysis, we used a log-linear mortality estimate from the CBC variables as a single quantitative measure of the aging process, henceforth referred to as dynamic organism state indicator (DOSI). We observed, that the age-dependent population DOSI distribution broadening could be explained by a progressive loss of physiological resilience measured by the DOSI auto-correlation time. Extrapolation of this trend suggested that DOSI recovery time and variance would simultaneously diverge at a critical point of 120 − 150 years of age corresponding to a complete loss of resilience. The observation was immediately confirmed by the independent analysis of correlation properties of intraday physical activity levels fluctuations collected by wearable devices. We conclude that the criticality resulting in the end of life is an intrinsic biological property of an organism that is independent of stress factors and signifies a fundamental or absolute limit of human lifespan.

T. Pyrkov, K. Avchaciov, A. Tarkhov, L. Menshikov, A. Gudkov, P. Fedichev

Read the article here

LINK TO ARTICLE
RECENT NEWS
Press Release
Press Release
Press Release
News
Chugai and Gero Enter into Joint Research and License Agreement to Develop Novel Therapies for Age-Related Diseases
July 7, 2025
Press Release
Press Release
Press Release
News
Physics-Powered GenAI Biotech Gero Raises $6M to Find Root Causes of Aging and Age-Related Diseases
October 18, 2023
Event
Press Release
Event
News
5th Age-Related Disease Therapeutics Summit
May 31, 2023
Press Release
Press Release
Press Release
News
Longevity Biotech Gero entered a research collaboration with Pfizer
January 6, 2023